Liquidyne Process Technologies, Inc

Liquidyne Process Technologies, Inc Liquidyne is a leader in high-purity fluid handling and measurement. We are dedicated to helping gro

Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 in Co...
12/02/2025

Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 in Combination with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) & TP53 mutant AML Patients

Shattuck Labs, Inc. announced updated interim data from the Phase 1B dose expansion clinical trial of SL-172154 in combination with AZA in frontline HR-MDS and TP53m AML patients.

Looking for best-in-class ๐‚๐ฎ๐ฌ๐ญ๐จ๐ฆ ๐๐ฎ๐ฆ๐ฉ ๐’๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ฌ for your process?  From simple to complex,  can help solve your most pre...
12/01/2025

Looking for best-in-class ๐‚๐ฎ๐ฌ๐ญ๐จ๐ฆ ๐๐ฎ๐ฆ๐ฉ ๐’๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ฌ for your process? From simple to complex, can help solve your most pressing process challenges. Learn more! https://liquidyneusa.com/pages/custom-pump-solutions-bipharma


Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositisโ„ข and RESET-SLEโ„ข Trials of CABA-201
12/01/2025

Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositisโ„ข and RESET-SLEโ„ข Trials of CABA-201

Cabaletta Bio, Inc. reported positive initial clinical data from each of the first two patients dosed with CABA-201 in the Phase 1/2 RESET-Myositis and RESET-SLE trials.

Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Dis...
11/30/2025

Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Disease, Presented at the European Hematology Association (EHA) Annual Congress

Editas Medicine, Inc., a clinical-stage genome editing company, announced new safety and efficacy data in 18 patients living with sickle cell disease treated with renizgamglogene autogedtemcel in the Phase 1/2/3 RUBY clinical trial.

Rigel Announces Five Presentations at the EHA2024 Hybrid Congress
11/29/2025

Rigel Announces Five Presentations at the EHA2024 Hybrid Congress

Rigel Pharmaceuticals, Inc. announced one oral and four poster presentations at the European Hematology Association 2024 Hybrid Congress in Madrid, Spain being held June 13-16, 2024, and online.

Honoring Impact: Trish Melton, PhD, Recognized with the 2025 ISPE Richard B. Purdy Distinguished Achievement Award
11/28/2025

Honoring Impact: Trish Melton, PhD, Recognized with the 2025 ISPE Richard B. Purdy Distinguished Achievement Award

The 2025 ISPE International Honor Awards took place during the Membership Meeting and Awards Lunch at the 2025 ISPE Annual Meeting & Expo hosted in Charlotte, North Carolina, USA from 26-29 October. The ceremony honored ISPE members and contributors whose dedication and service exemplify what it mea...

How Generative AI is Transforming Deviation Management: Lessons from Integrating Microsoft Copilot in Pharma Quality Sys...
11/27/2025

How Generative AI is Transforming Deviation Management: Lessons from Integrating Microsoft Copilot in Pharma Quality Systems

Introduction: The Human Challenge Behind Deviation ManagementA deviation is more than a record of non-conformance; it is a narrative of how an organization understands its processes and strengthens them. In pharmaceutical manufacturing, deviation management forms the foundation of product quality, r...

Tired of leaky tubing nightmares? Banish stress with the BarbLock Ultra-Secure Retainer Sale!๐’๐ก๐จ๐ฉ ๐๐จ๐ฐ & ๐‹๐ž๐š๐ค๐ฉ๐ซ๐จ๐จ๐Ÿ ๐˜๐จ๐ฎ๐ซ ๐‹...
11/27/2025

Tired of leaky tubing nightmares? Banish stress with the BarbLock Ultra-Secure Retainer Sale!
๐’๐ก๐จ๐ฉ ๐๐จ๐ฐ & ๐‹๐ž๐š๐ค๐ฉ๐ซ๐จ๐จ๐Ÿ ๐˜๐จ๐ฎ๐ซ ๐‹๐ข๐Ÿ๐ž: https://liquidyneusa.com/products/barblock-ultra-secure-retainers
Secure your peace of mind (and your fluids!) with 20% off BarbLock retainers. This isn't your average zip tie - it's a leak-proof, 360ยฐ crimping champion that:
๐‹๐จ๐œ๐ค๐ฌ ๐ญ๐ข๐ ๐ก๐ญ: Say goodbye to accidental disconnects and pressure drops.
๐–๐จ๐ซ๐ค๐ฌ ๐ฐ๐ข๐ญ๐ก ๐€๐‹๐‹ ๐ญ๐ฎ๐›๐ข๐ง๐  ๐ฆ๐š๐ญ๐ž๐ซ๐ข๐š๐ฅ๐ฌ: Versatile hero, ready to save the day.
๐”๐’๐ ๐‚๐ฅ๐š๐ฌ๐ฌ ๐•๐ˆ ๐œ๐ž๐ซ๐ญ๐ข๐Ÿ๐ข๐ž๐: Safe for even the most sensitive applications.
๐ƒ๐ฎ๐ซ๐š๐›๐ฅ๐ž: Built to last, built to impress.
This sale won't last long, so grab your BarbLock retainers for up to 50% off before they're gone!
๐’๐ก๐จ๐ฉ ๐๐จ๐ฐ & ๐‹๐ž๐š๐ค๐ฉ๐ซ๐จ๐จ๐Ÿ ๐˜๐จ๐ฎ๐ซ ๐‹๐ข๐Ÿ๐ž: https://liquidyneusa.com/products/barblock-ultra-secure-retainers

2025 ISPE Pharma 4.0โ„ข Conference
11/27/2025

2025 ISPE Pharma 4.0โ„ข Conference

Join pharma leaders at ISPEโ€™s 2025 Pharma 4.0โ„ข Conference in Barcelona. Explore AI, automation, and digital transformation shaping the future of pharma.

Address

11925 W Interstate 70 Frontage Rd N # 700
Wheat Ridge, CO
80033

Opening Hours

Monday 7:30am - 5pm
Tuesday 7:30am - 5pm
Wednesday 7:30am - 4:30pm
Thursday 7:30am - 4:30pm
Friday 7:30am - 4:30pm

Telephone

+13032059050

Alerts

Be the first to know and let us send you an email when Liquidyne Process Technologies, Inc posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Liquidyne Process Technologies, Inc:

Share